Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 483 |
|---|
Dr. Yvette M. Bordelon, MD, PhD is a null in Los Angeles, CA specializing in psychiatry & neurology and neurology (brain & spinal cord disease). She graduated from University of Pennsylvania School of Medicine in 1999 and has 27 years of experience. Dr. Yvette M. Bordelon, MD, PhD is affiliated with UCLA Health, Ronald Reagan UCLA Medical Center and Cedars-Sinai.
Deep Brain Stimulation (DBS)
Deep brain stimulation (DBS) is a procedure performed to help treat neurological conditions such as Parkinson's disease and epilepsy. Electrode leads are surgically implanted in the brain and connected to a device, called a neurostimulator (deep brain stimulator), that is placed underneath the skin (subcutaneously). The deep brain stimulator can send electrical signals through the electrodes to the brain to restore normal rhythms, or it can block electrical signals in specific areas of the brain to restore functioning. Although not a cure, DBS can treat symptoms of movement disorders such as pain and tremor when medication fails to work.
DBS surgery may be completed in one operating session, but it is more commonly performed in two parts. In the first stage of the procedure, the surgeon will map targets in the brain using CT or MRI imaging to determine where to place the electrodes. Then, by drilling holes into the skull, the surgeon will place the electrodes into specific areas in the brain. The holes will be closed, and patients will require 1-2 days to recover in the hospital. After about two weeks, patients will undergo another surgery to have the deep brain stimulator implanted. The stimulator is usually placed under the skin around the collarbone, chest, or abdomen, and it will be connected to the DBS electrodes through a subcutaneous wire. No component of the DBS system will be visible from outside. Following stimulator implantation, patients may need to recover in the hospital for 1-2 days.
Within 2-4 weeks of the operation, doctors will program the stimulator using a wireless device. Patients will work with their doctor to determine the most effective settings for the stimulator during follow-up visits. Patients will be given a handheld device so that they can turn the stimulator on or off and adjust its settings themselves. The stimulator may have a rechargeable battery, in which case patients will be given a charging unit. Stimulator batteries generally need to be replaced in 3-5 years.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 483 |
|---|
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2013 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 589 |
|---|---|
| hospital care | 24 |
| inpatient care | 24 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 153 |
|---|---|
| Female | 122 |
| Non-Hispanic White | 213 |
|---|---|
| Black | 0 |
| Hispanic | 26 |
| Asian | 20 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 115 |
|---|---|
| From 75 to 84 | 83 |
| 85 and over | 32 |
| Less than 65 | 45 |
| Hypertension | 59 |
|---|---|
| High Cholesterol | 45 |
| Stroke | 11 |
| Ischemic Heart Disease | 35 |
| Depression | 33 |
| Chronic Kidney Disease | 19 |
| Asthma | 4 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 11 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 9 |
| Diabetes | 17 |
| Dementia | 25 |
| Cancer | 9 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 741 |
|---|
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 192 |
|---|---|
| Female | 140 |
| Non-Hispanic White | 233 |
|---|---|
| Black | 13 |
| Hispanic | 49 |
| Asian | 25 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 139 |
|---|---|
| From 75 to 84 | 93 |
| 85 and over | 35 |
| Less than 65 | 65 |
| Hypertension | 54 |
|---|---|
| High Cholesterol | 43 |
| Stroke | 5 |
| Ischemic Heart Disease | 33 |
| Depression | 31 |
| Chronic Kidney Disease | 20 |
| Asthma | 6 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 8 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 20 |
| Dementia | 28 |
| Cancer | 10 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 936 |
|---|
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 448 |
|---|---|
| Female | 320 |
| Non-Hispanic White | 564 |
|---|---|
| Black | 0 |
| Hispanic | 102 |
| Asian | 48 |
| Other | 32 |
| Native American | 0 |
| From 65 to 74 | 338 |
|---|---|
| From 75 to 84 | 220 |
| 85 and over | 78 |
| Less than 65 | 132 |
| Hypertension | 52 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 6 |
| Ischemic Heart Disease | 32 |
| Depression | 33 |
| Chronic Kidney Disease | 17 |
| Asthma | 7 |
| Osteoperosis | 10 |
| Atrial Fibrilation | 9 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 20 |
| Dementia | 29 |
| Cancer | 11 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2016 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 938 |
|---|---|
| hospital care | 23 |
| inpatient care | 23 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 225 |
|---|---|
| Female | 192 |
| Non-Hispanic White | 301 |
|---|---|
| Black | 0 |
| Hispanic | 61 |
| Asian | 28 |
| Other | 13 |
| Native American | 0 |
| From 65 to 74 | 184 |
|---|---|
| From 75 to 84 | 123 |
| 85 and over | 39 |
| Less than 65 | 71 |
| Hypertension | 56 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 7 |
| Ischemic Heart Disease | 35 |
| Depression | 36 |
| Chronic Kidney Disease | 22 |
| Asthma | 10 |
| Osteoperosis | 15 |
| Atrial Fibrilation | 9 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 25 |
| Dementia | 34 |
| Cancer | 12 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2017 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 835 |
|---|---|
| hospital care | 15 |
| inpatient care | 15 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 211 |
|---|---|
| Female | 153 |
| Non-Hispanic White | 265 |
|---|---|
| Black | 15 |
| Hispanic | 47 |
| Asian | 23 |
| Other | 14 |
| Native American | 0 |
| From 65 to 74 | 146 |
|---|---|
| From 75 to 84 | 125 |
| 85 and over | 30 |
| Less than 65 | 63 |
| Hypertension | 54 |
|---|---|
| High Cholesterol | 46 |
| Stroke | 7 |
| Ischemic Heart Disease | 36 |
| Depression | 38 |
| Chronic Kidney Disease | 22 |
| Asthma | 6 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 8 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 9 |
| Diabetes | 22 |
| Dementia | 33 |
| Cancer | 12 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 796 |
|---|
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 206 |
|---|---|
| Female | 141 |
| Non-Hispanic White | 263 |
|---|---|
| Black | 0 |
| Hispanic | 42 |
| Asian | 20 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 138 |
|---|---|
| From 75 to 84 | 124 |
| 85 and over | 32 |
| Less than 65 | 53 |
| Hypertension | 52 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 5 |
| Ischemic Heart Disease | 31 |
| Depression | 41 |
| Chronic Kidney Disease | 23 |
| Asthma | 3 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 7 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 21 |
| Dementia | 33 |
| Cancer | 12 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2019 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 756 |
|---|---|
| hospital care | 36 |
| inpatient care | 36 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 206 |
|---|---|
| Female | 142 |
| Non-Hispanic White | 260 |
|---|---|
| Black | 0 |
| Hispanic | 46 |
| Asian | 0 |
| Other | 18 |
| Native American | 0 |
| From 65 to 74 | 142 |
|---|---|
| From 75 to 84 | 124 |
| 85 and over | 24 |
| Less than 65 | 58 |
| Hypertension | 52 |
|---|---|
| High Cholesterol | 51 |
| Stroke | 7 |
| Ischemic Heart Disease | 33 |
| Depression | 45 |
| Chronic Kidney Disease | 24 |
| Asthma | 5 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 8 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 20 |
| Dementia | 30 |
| Cancer | 9 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 613 |
|---|
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 182 |
|---|---|
| Female | 109 |
| Non-Hispanic White | 214 |
|---|---|
| Black | 0 |
| Hispanic | 34 |
| Asian | 15 |
| Other | 15 |
| Native American | 0 |
| From 65 to 74 | 116 |
|---|---|
| From 75 to 84 | 106 |
| 85 and over | 23 |
| Less than 65 | 46 |
| Hypertension | 53 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 5 |
| Ischemic Heart Disease | 36 |
| Depression | 43 |
| Chronic Kidney Disease | 25 |
| Asthma | 4 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 8 |
| Heart Failure | 11 |
| Chronic Obstructive Pulmonary Disease | 4 |
| Diabetes | 21 |
| Dementia | 30 |
| Cancer | 9 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2021 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 608 |
|---|---|
| hospital care | 20 |
| inpatient care | 20 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 165 |
|---|---|
| Female | 105 |
| Non-Hispanic White | 194 |
|---|---|
| Black | 0 |
| Hispanic | 40 |
| Asian | 0 |
| Other | 15 |
| Native American | 0 |
| From 65 to 74 | 109 |
|---|---|
| From 75 to 84 | 98 |
| 85 and over | 19 |
| Less than 65 | 44 |
| Hypertension | 49 |
|---|---|
| High Cholesterol | 53 |
| Stroke | 4 |
| Ischemic Heart Disease | 33 |
| Depression | 38 |
| Chronic Kidney Disease | 28 |
| Asthma | 7 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 9 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 19 |
| Dementia | 30 |
| Cancer | 10 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 555 |
|---|---|
| hospital care | 19 |
| inpatient care | 19 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 151 |
|---|---|
| Female | 101 |
| Non-Hispanic White | 179 |
|---|---|
| Black | 0 |
| Hispanic | 42 |
| Asian | 12 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 101 |
|---|---|
| From 75 to 84 | 90 |
| 85 and over | 26 |
| Less than 65 | 35 |
| Hypertension | 62 |
|---|---|
| High Cholesterol | 62 |
| Stroke | 11 |
| Ischemic Heart Disease | 26 |
| Depression | 41 |
| Chronic Kidney Disease | 17 |
| Asthma | 9 |
| Osteoperosis | 18 |
| Atrial Fibrilation | 17 |
| Heart Failure | 16 |
| Chronic Obstructive Pulmonary Disease | 5 |
| Diabetes | 21 |
| Dementia | 24 |
| Cancer | 12 |
The top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA during 2023 were hospital care and inpatient care.
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 446 |
|---|---|
| hospital care | 17 |
| inpatient care | 17 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 134 |
|---|---|
| Female | 101 |
| Non-Hispanic White | 177 |
|---|---|
| Black | 0 |
| Hispanic | 35 |
| Asian | 0 |
| Other | 12 |
| Native American | 0 |
| From 65 to 74 | 89 |
|---|---|
| From 75 to 84 | 88 |
| 85 and over | 28 |
| Less than 65 | 30 |
| Hypertension | 62 |
|---|---|
| High Cholesterol | 66 |
| Stroke | 8 |
| Ischemic Heart Disease | 29 |
| Depression | 40 |
| Chronic Kidney Disease | 17 |
| Asthma | 9 |
| Osteoperosis | 20 |
| Atrial Fibrilation | 17 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 23 |
| Dementia | 22 |
| Cancer | 11 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
| doctor visit | 578 |
|---|
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Male | 135 |
|---|---|
| Female | 127 |
| Non-Hispanic White | 205 |
|---|---|
| Black | 0 |
| Hispanic | 21 |
| Asian | 17 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 90 |
|---|---|
| From 75 to 84 | 116 |
| 85 and over | 31 |
| Less than 65 | 25 |
| Hypertension | 69 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 18 |
| Ischemic Heart Disease | 34 |
| Depression | 39 |
| Chronic Kidney Disease | 22 |
| Asthma | 13 |
| Osteoperosis | 25 |
| Atrial Fibrilation | 21 |
| Heart Failure | 20 |
| Chronic Obstructive Pulmonary Disease | 10 |
| Diabetes | 26 |
| Dementia | 25 |
| Cancer | 15 |
Volume of procedures performed by Dr. Yvette M. Bordelon, MD, PhD for Medicare patients.
The highest averages for the top procedures that Dr. Yvette M. Bordelon, MD, PhD treated as a null in Los Angeles, CA were hospital care and inpatient care.
| doctor visit | 682 |
|---|---|
| hospital care | 22 |
| inpatient care | 22 |
Information about Medicare patients treated by Dr. Yvette M. Bordelon, MD, PhD.
| Female | 134 |
|---|---|
| Male | 185 |
| Black / African American | 2 |
|---|---|
| Asian / Pacific Islander | 16 |
| Non-Hispanic White | 236 |
| Hispanic | 41 |
| Native American / Alaskan Native | 0 |
| Other | 9 |
| 85 and over | 30 |
|---|---|
| 75 to 84 | 106 |
| Less than 65 | 51 |
| 65 to 74 | 131 |
The highest averages of the most common conditions of Medicare patients that Dr. Yvette M. Bordelon, MD, PhD treated were hypertension, high cholesterol, depression and ischemic heart disease.
| Hypertension | 51 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 7 |
| Ischemic Heart Disease | 30 |
| Depression | 35 |
| Chronic Kidney Disease | 19 |
| Asthma | 6 |
| Osteoporosis | 13 |
| Heart Failure | 14 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 19 |
| Atrial Fibrillation | 10 |
| Cancer | 10 |
| Dementia | 26 |
Dr. Yvette M. Bordelon, MD, PhD graduated from University of Pennsylvania School of Medicine in 1999. She completed residency at Massachusetts General Hospital. She is certified by the American Board of Psychiatry and Neurology and has a state license in California.
Medical School: University of Pennsylvania School of Medicine (1999)
Residency: Massachusetts General Hospital (2003)
Board Certification: American Board of Psychiatry and Neurology
Licensed In: California
Dr. Yvette M. Bordelon, MD, PhD appears to accept the following insurance providers: Cigna, Private Healthcare Systems (PHCS), TRICARE, Aetna, Blue Shield of California, MultiPlan, Anthem, UnitedHealthcare, Medicare Advantage, Prime Health, First Health, HealthSmart, Centivo, Health Net of California and UFCM Health System.
According to our sources, Dr. Yvette M. Bordelon, MD, PhD accepts the following insurance providers:
Dr. Yvette M. Bordelon, MD, PhD has an exceptional overall rating with an average of 4.92 out of 5 stars based on 335 ratings. We collect ratings and reviews of Dr. Yvette M. Bordelon, MD, PhD from all over the web to help you find the right in Los Angeles, CA.
These charts describe general payments received by Dr. Yvette M. Bordelon, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Teva Pharmaceuticals USA, Inc. |
$29,194
AZILECT $29,090 |
Austedo XR $84 |
NUVIGIL $7 |
COPAXONE $6 |
$7 |
|
|---|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc. |
$4,942
INGREZZA $108 |
ONGENTYS $64 |
$4,770 |
|||
| Boston Scientific Corporation |
$830
GENERAL - DBS $163 |
$667 |
||||
| Abbott Laboratories |
$439
Infinity $439 |
|||||
| Medtronic, Inc. |
$349
PERCEPT PC BRAINSENSE $136 |
$213 |
||||
| Other |
$642
NUPLAZID $293 |
Deep Brain Neurostimulation $71 |
ACTIVA $57 |
EXELON PATCH $45 |
VYALEV $43 |
Other $132 |
| Honoraria | $14,950 |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,000 |
| Consulting Fee | $5,220 |
| Food and Beverage | $2,571 |
| Travel and Lodging | $1,507 |
| Other | $150 |
Dr. Yvette M. Bordelon, MD, PhD has received 69 research payments totaling $883,825.
Dr. Yvette Bordelon sees patients in Los Angeles, CA. Her medical specialty is neurology (brain & spinal cord disease). She studied medicine at the University of Pennsylvania School of Medicine. Dr. Bordelon's medical residency was performed at Brigham and Women's Hospital, Massachusetts General Hospital, and a hospital affiliated with Harvard Medical School. Her areas of expertise consist of parkinson's disease, neurosurgery, and essential tremor. Her patients gave her an average rating of 5.0 stars (out of 5). Anthem, UnitedHealthcare, and Blue California seem to be the insurance carriers that Dr. Bordelon accepts. Dr. Bordelon has received professional recognition including the following: Southern California Super Doctors; Southern California Rising Stars; and Super Doctors® Southern California. She is professionally affiliated with Cedars-Sinai and Ronald Reagan UCLA Medical Center. Her practice in Los Angeles, CA is open to new patients as reported by Cedars-Sinai.